 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
0 News |  |
- || ANB-004 / Biocad
New P1/2 trial, Viral vector: Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous Administration of Escalating Doses in Children With Spinal Muscular Atrophy (BLUEBELL) (clinicaltrials.gov) - Feb 28, 2023
P1/2, N=40, Recruiting, Sponsor: Biocad